CGC Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CGC Financial Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5	Closed	-$406	–	352
2025 Q1	$406	Hold	5	–	–	﹤0.01%	314
2024 Q4	$450	Hold	5	–	–	﹤0.01%	320
2024 Q3	$494	Hold	5	–	–	﹤0.01%	313
2024 Q2	$464	Hold	5	–	–	﹤0.01%	319
2024 Q1	$474	Hold	5	–	–	﹤0.01%	324
2023 Q4	$446	Hold	5	–	–	﹤0.01%	337
2023 Q3	$365	Hold	5	–	–	﹤0.01%	307
2023 Q2	$416	Buy	+5	New	+$418	﹤0.01%	326

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

CGC Financial Services's XBI Position: Q2 2025 in Review

CGC Financial Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 5 shares — an estimated $406 sold.

CGC Financial Services first reported a position in XBI in Q2 2023 and held it in 8 quarters. The position peaked at $494 in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

CGC Financial Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
CGC Financial Services sold 5 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $406.
CGC Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and held it in 8 quarters.
CGC Financial Services's State Street SPDR S&P Biotech ETF position peaked at $494 in Q3 2024.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on CGC Financial Services's 13F filing for Q2 2025, filed 28 Jul 2025.